In this regard, it is interesting that the JIMT-1 breast cancer cell line, a model of intrinsic resistance to trastuzumab that harbors an activating mutation in the PIK3CA gene and low expression of PTEN [69], was notably responsive to metformin in vitro and in vivo [70, 71]. The gene discussed is PIK3CA; the disease is breast carcinoma.